spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

AirBridgeCargo expands its passive pharma solutions in partnership with SkyCell as it achieves the two-fold volume increase

AirBridgeCargo Airlines


AirBridgeCargo expands its passive pharma solutions in partnership with SkyCell as it achieves the two-fold volume increase AirBridgeCargo Airlines (ABC), one of the leaders in transportation of pharmaceutical products by air, and Zurich-based cold-chain ULD manufacturer SkyCell have sealed their partnership for the lease of all types of SkyCell containers to meet the demand for evolving volumes of passive pharmaceutical shipments, which reached around 3,500 tonnes for 1Q 2019 YOY and demonstrated a two-fold increase.

The SkyCell line of passive containers is capable of keeping the internal temperature within the range of +2° to +8°C and +15°C to +25°C under external temperature excursions from –35°C to +65°C to meet the requirements of various pharmaceutical manufacturers, as well as logistics companies involved in a complex transportation process.

“With SkyCell containers we have increased the total number of cold-chain special packaging solutions partners till three, aiming at embracing all leading manufacturers to cater to the needs of different customers. SkyCell data-collection enablement supports our intention to move further with ‘Internet of Things’ penetration into the industry and step aside from peer-to-peer data sharing to information transparency and availability. On top of this, it fosters an extra piece of mind for our customers to have real-time data in one click,” – stated Fedor Novikov, Deputy General Director, Products, AirBridgeCargo Airlines.

“ABC has one of the most modern airline fleets and, like SkyCell, is committed to greater transparency in the industry. Together we strive to make pharmaceutical logistics safer, more reliable and more sustainable.” said Richard Ettl, CEO of SkyCell.

AirBridgeCargo has adapted a thorough and well-balanced approach towards development of its dedicated ‘abc pharma’ product, reinforcing its team of experts, expanding its pool of special packaging manufacturers, adopting the latest digital solutions, but most importantly, deepening its field-specific knowledge and sharing it with customers and partners through educational workshops and aircraft tours.

About AirBridgeCargo Airlines

AirBridgeCargo is one of the global cargo carriers with an expanded international route network which connects customers in the largest trans-regional markets of Asia, Europe, and North America and covers more than 30 major cargo gateways, accommodating trade flows worldwide. All the flights are operated via ABC’s cargo hub in Moscow Sheremetyevo airport, featuring up-to-date equipment and guaranteeing seamless connection throughout the airline’s expanded international network within a 48-hour delivery time, including handling, all managed by highly skilled and qualified ground handling personnel. ABC’s fleet consists of 18 Boeing 747 freighters and is one of the youngest and most modern in the airline industry.
More information – www.airbridgecargo.com

About SkyCell

SkyCell is a leading airfreight container provider with the mission to supply the safest pharma containers worldwide. This is achieved through the unique combination of hardware, software and service, enabling our clients to master logistical challenges and eliminate temperature excursion. Pharma companies have tested and verified SkyCell as the safest solution on the market, with less than 0.1% temperature deviations since launch. The efficient insulation and cutting-edge cooling technology enable the containers to keep the temperature for 160h+. All containers are equipped with IoT sensors, leading to a seamless supply chain through global tracking and monitoring. Based in Switzerland and with a global service station network, SkyCell is serving pharma companies around the world. For more information visit www.skycell.ch
phone + 7 495 7862613
email info@airbridgecargo.com
web www.airbridgecargo.com
email Building 16/1, Malaya Pirogovskaya, Moscow 119435
 
Print this page
Send to a friend
   
spacer
News and Press Releases

The need for a blueprint emergency plan to avoid a HPAPI crisis

SMi reports: Taro Pharmaceuticals, Purdue Pharma and Sakari Consultants to present at HPAPI USA taking place on October 21st – 22nd in Boston
More info >>


White Papers

The Importance of ADCC in Assessing Clinically Relevant Differences

Sartorius Stedim BioOutsource Ltd

Biosimilars have caused a revolution in the development of biologic drugs. The model for biosimilars is a combination of speed to market and low cost; these are fundamental to any biosimilar development project. The biosimilars pathway to approval is not always without difficulty, biosimilars are still relatively new, and as each new applicant is reviewed we are learning more and more about these molecules.
More info >>

Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India for high quality, low cost pharma solutions, CPhI & P-MEC India is the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India's pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement